Bio-Path Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Vik Grover
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.9yrs |
| Board average tenure | 8.1yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Rate
Nov 05
Bio-Path GAAP EPS of -$0.42 beats by $0.07
Aug 16Is Bio-Path Holdings (NASDAQ:BPTH) In A Good Position To Deliver On Growth Plans?
Jul 08Here's Why We're Not Too Worried About Bio-Path Holdings' (NASDAQ:BPTH) Cash Burn Situation
Mar 24Bio-Path Holdings (NASDAQ:BPTH) Is In A Good Position To Deliver On Growth Plans
Aug 17We Think Bio-Path Holdings (NASDAQ:BPTH) Needs To Drive Business Growth Carefully
Mar 26CEO
Vik Grover (55 yo)
Mr. Vikram Paul Grover, also known as Vik, CFA., Esq., is President, CEO, CFO & Director of Bio-Path Holdings, Inc. from October 22, 2025. He serves as an Additional Non-Executive Independent Director of V...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 18.9yrs | US$81.78k | 0% $ 0 | |
| President | less than a year | no data | no data | |
| VP of Clinical Operations | 2.9yrs | no data | no data | |
| Senior Vice President of Finance | no data | no data | no data | |
| Senior Vice President of Research | no data | no data | no data |
Experienced Management: BPTH's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | no data | |
| Chairman of the Scientific Advisory Board | 10.3yrs | no data | no data | |
| Member of the Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of the Scientific Advisory Board | 8.8yrs | no data | no data |
Experienced Board: BPTH's board of directors are considered experienced (8.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/31 13:43 |
| End of Day Share Price | 2025/12/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bio-Path Holdings, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Kolbert | Maxim Group |
| Pamela Bassett | Maxim Group |